Mounjaro Dosing Explained: What is the Average Dose for Mounjaro?

Last reviewed: July 10, 2026

Last updated: July 10, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide is a dual GIP and GLP-1 receptor agonist that requires a structured dosing approach to maximize effectiveness and tolerability. Unlike fixed-dose medications, tirzepatide therapy begins at a low dose and increases incrementally over weeks, allowing your body to adapt while your healthcare provider monitors your progress. Understanding how dosing works helps you set realistic expectations for your weight loss journey.

How Tirzepatide Dosing Works: The Step-Up Protocol

Tirzepatide dosing follows a four-step escalation schedule designed by clinical research to balance safety and efficacy. Most patients begin at 2.5 mg once weekly, remaining at this dose for four weeks to assess tolerance and initial response. After the first month, the dose typically increases to 5 mg weekly, then continues stepping up to 7.5 mg and finally 10 mg at four-week intervals. This gradual progression reduces nausea and gastrointestinal side effects compared to starting at higher doses.

The maintenance dose varies significantly between individuals based on weight loss response, side effect tolerance, and baseline metabolism. Some patients achieve their weight loss goals at 7.5 mg weekly, while others benefit from reaching the 10 mg or 12.5 mg maximum dose. PlexusDx compounded tirzepatide allows your prescriber to customize your escalation timeline and target maintenance dose based on your specific body composition, medical history, and genetic predispositions to peptide pathway activation.

Average Maintenance Doses and Clinical Outcomes

Clinical trials show that average maintenance doses range from 7.5 to 10 mg weekly, with most patients stabilizing at 10 mg for sustained weight management. The SURMOUNT trials demonstrated that patients on 10 mg tirzepatide achieved approximately 22% body weight reduction over 72 weeks, compared to 16% at the 5 mg dose. However, the average effective dose is highly individualized—some patients experience plateau weight loss at 7.5 mg and do not benefit from further escalation, while others require the full 12.5 mg or 15 mg dose for continued progress.

Your prescriber determines your target maintenance dose by monitoring your weekly weight trends, appetite suppression level, and tolerability to gastrointestinal effects. Once you reach a dose where weight loss stabilizes and side effects remain manageable, that becomes your maintenance dose, which you continue indefinitely or adjust seasonally based on lifestyle changes. PlexusDx partners with licensed prescribers who track your progress through structured follow-ups and adjust your compounded tirzepatide strength monthly if needed.

Why Compounded Tirzepatide Offers Flexible Dosing Options

Compounded tirzepatide from licensed 503A pharmacies provides dosing flexibility that brand-name formulations cannot match, allowing prescribers to customize concentrations and volumes for your exact therapeutic needs. If you respond best to 6 mg weekly instead of the standard 5 mg or 7.5 mg steps, a compounding pharmacy can prepare your injection at precisely that strength. This precision dosing reduces medication waste, minimizes cost per milligram, and eliminates the need to use partial vials or adjust injection volumes to achieve intermediate doses.

PlexusDx compounded tirzepatide injections start at $289/mo (or $249/mo on the 6-month plan) regardless of your current dose, meaning your dose may increase as your body requires, but your price remains stable. This flat-rate pricing model removes the financial barrier to dose optimization, allowing you to work with your provider to find your ideal maintenance dose without worrying about escalating medication costs. Licensed 503A compounding ensures pharmaceutical-grade quality, sterility, and potency equivalent to brand products.

Genetic Testing and Personalized Dosing Strategies

Individual genetic variations in GLP-1 and GIP receptor sensitivity explain why some patients require lower doses while others need maximum strength to achieve weight loss. The PlexusDx Precision Peptide Genetic Test identifies your genetic profile across 14 peptide pathways and 150+ clinical insights, including variants in the GLP1R (rs6923761) and GIPR (rs1800437) genes that influence your medication response. Patients with certain genetic variants may achieve significant weight loss at lower maintenance doses, while those with others benefit from faster escalation schedules.

After your first month of tirzepatide therapy with PlexusDx, you can add the Precision Peptide Genetic Test for $99 to map your peptide pathway genetics and refine your dosing strategy. This test informs whether your prescriber should pursue standard escalation, extended holding periods at lower doses, or faster progression toward maximum strength. Understanding your genetic predisposition to receptor activation helps your provider make evidence-based decisions about your ideal maintenance dose and reduces trial-and-error adjustments.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the starting dose of tirzepatide, and how long do I stay on it?

Most tirzepatide patients begin at 2.5 mg weekly for four weeks, allowing your body to adapt before increasing. PlexusDx prescribers may extend your time at the starting dose if you experience side effects, or progress faster if you tolerate the medication well. Your starting dose depends on your baseline health, body weight, and prior GLP-1 experience.

Is there a maximum dose for tirzepatide?

The maximum approved dose is 15 mg weekly, though most patients achieve their weight loss goals between 7.5 and 10 mg. Clinical evidence shows diminishing returns beyond 10 mg for many individuals, and your PlexusDx prescriber will determine if escalating past your current dose offers additional benefit or only increases side effects.

How much does tirzepatide cost at different dose levels?

PlexusDx compounded tirzepatide injections are priced at a flat $289/mo (or $249/mo on the 6-month plan), regardless of your current or target dose—your dose may increase as your body requires, but your price won't. This pricing structure ensures you can work toward your ideal maintenance dose without financial penalties for dose escalation.

Can I switch between different doses of tirzepatide without restarting the protocol?

Yes, dose adjustments during your maintenance phase do not require restarting the four-week escalation schedule. If your prescriber increases or decreases your dose based on your response, you can transition directly without a washout period. PlexusDx's monthly compounding allows seamless dose changes as your body composition and weight loss goals evolve.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

The test maps your genetic variants in GLP1R and GIPR receptor genes and 12 other peptide pathways, providing your prescriber with insights into your likely medication responsiveness. While genetics don't guarantee your exact maintenance dose, understanding your genetic profile helps your PlexusDx prescriber make informed decisions about escalation timing and maximum target dose, reducing months of trial-and-error adjustments.

Related Reading

• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension
• Mounjaro For Endometriosis

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.